Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Horizons

University of Toronto

$98,000.00

eTextiles and Automation Technology in Physical Therapy Practice in Critical Care: An Interdisciplinary Research Approach to Medical Device Development

EF 2024-25

Résumé
Intensive Care Unit-Acquired Weakness, or ICUAW, is muscle weakness experienced by the critically ill due to bedrest, sedation, and restricted mobility compounded by mechanical ventilation. Patients aged 66 years or older, on mechanical ventilation for a week or more, face a 50% likelihood of never returning to their accustomed levels of activity, despite therapeutic interventions. Neuromuscular Electrical Stimulation (NMES) therapy can prevent muscle loss and maintain strength in the critically ill, preventing the onset of ICUAW, when participation in exercise or mobilization therapy is not possible. NMES involves the application of electrical impulses to stimulate muscle contraction. Implementing NMES therapy within ICU settings is challenging. It requires extensive clinician resources as they work one-on-one with patients to treat the muscles of the upper and lower limbs frequently enough and for long enough, for every patient in the ICU. In response to this challenge, we are developing etextiles, wearable, fabric-based devices that integrate electronic sensors and actuators, offering a potential breakthrough in the delivery of NMES therapy in the ICU. These wearables not only facilitate targeted NMES therapy but will also be designed to monitor muscle contractions and heart rate, delivering invaluable insights into therapy efficacy and patient comfort. This necessitates the development of critical measurement techniques and machine learning algorithms to assess muscle contractions and detect patient discomfort in real time during NMES. We are an interdisciplinary group of physiotherapists, medical practitioners, computer scientists, and engineers. This interdisciplinary approach extends beyond the laboratory, as we are firmly committed to engaging patients, caregivers, and influential healthcare stakeholders, including administrators, in an innovative co-design process. By collaborating closely with these stakeholders, we aim to ensure that our etextile solutions align optimally with the real-world requirements and expectations of end-users. The technological advancements we are proposing will optimize patient outcomes, reduce complications, and ultimately contribute to better patient care and recovery.
Programme
Discovery Horizons
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
DH-2024-00163
Name nom
Gabison, Sharon
Department département
KITE - University Health Network
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
98000
Program id
DH
Program name en
Discovery Horizons
Program name fr
Horizons de la découverte
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
nan
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF2070101
Field of research list names en
Biomedical materials
Field of research list names fr
Matériaux biomédicaux
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
eTextiles and Automation Technology in Physical Therapy Practice in Critical Care: An Interdisciplinary Research Approach to Medical Device Development
Keywords
Medical Devices; eTextiles; Electrical Muscle Stimulation; ICU; ICU-Acquired Weakness
Application summary
Intensive Care Unit-Acquired Weakness, or ICUAW, is muscle weakness experienced by the critically ill due to bedrest, sedation, and restricted mobility compounded by mechanical ventilation. Patients aged 66 years or older, on mechanical ventilation for a week or more, face a 50% likelihood of never returning to their accustomed levels of activity, despite therapeutic interventions. Neuromuscular Electrical Stimulation (NMES) therapy can prevent muscle loss and maintain strength in the critically ill, preventing the onset of ICUAW, when participation in exercise or mobilization therapy is not possible. NMES involves the application of electrical impulses to stimulate muscle contraction. Implementing NMES therapy within ICU settings is challenging. It requires extensive clinician resources as they work one-on-one with patients to treat the muscles of the upper and lower limbs frequently enough and for long enough, for every patient in the ICU. In response to this challenge, we are developing etextiles, wearable, fabric-based devices that integrate electronic sensors and actuators, offering a potential breakthrough in the delivery of NMES therapy in the ICU. These wearables not only facilitate targeted NMES therapy but will also be designed to monitor muscle contractions and heart rate, delivering invaluable insights into therapy efficacy and patient comfort. This necessitates the development of critical measurement techniques and machine learning algorithms to assess muscle contractions and detect patient discomfort in real time during NMES. We are an interdisciplinary group of physiotherapists, medical practitioners, computer scientists, and engineers. This interdisciplinary approach extends beyond the laboratory, as we are firmly committed to engaging patients, caregivers, and influential healthcare stakeholders, including administrators, in an innovative co-design process. By collaborating closely with these stakeholders, we aim to ensure that our etextile solutions align optimally with the real-world requirements and expectations of end-users. The technological advancements we are proposing will optimize patient outcomes, reduce complications, and ultimately contribute to better patient care and recovery.